This past week, Sony introduced its latest portable Bluetooth speakers for summer, Fujifilm revealed its vintage-inspired ...

If Madison Square Garden is basketball’s Mecca, Devin Booker didn’t take his visit Sunday night lightly. Booker broke out not ...

40% of Merck & Co., Inc.'s revenues are driven by cancer med Keytruda, which faces patent expiry by 2028, posing a significant risk to future earnings and share price value. The company is ...

GLP-1s are driving traditional drug spending in the U.S. to unprecedented levels, which now outpaces specialty drug spending for the first time, according to a March 25 report from Evernorth.

A review of randomized clinical trials found 33 occurrences of suicide-related behaviors with GLP-1s vs 27 for placebo. Data showed no outcome differences based on diabetes status or type of GLP-1 ...

Two "Rare Air" Air Jordan 1s release in April. Via Nike Jordan Brand is planning to release two new "Rare Air" colorways of the ever-popular Air Jordan 1 High in early April, including one women's ...

The patent dispute dates back to December 2022, when Samsung Display filed complaints against 17 component wholesalers in the United States. In the complaints, Samsung Display argued that OLEDs it ...

With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that have taken the leap off the patent cliff. Big Pharma is staring down the ...

The reason for filing the patent in a foreign country is as follows: Section 39 state that the residents will not apply for patents outside India without prior permission. Any person who is a resident ...

You're already imagining what it sounds like. We are. Looks like Ferrari has submitted a patent design for a new V12 that uses oval-shaped pistons. Pistons, as you're probably aware, are famously ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy.